Last update:

Immunology news

Diseases, Conditions, Syndromes

Unique immune cell linked to aggressive leukemia may lead to improved treatment outcomes

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults. The discovery of a previously ...

Immunology

Study uncovers how the immune system fends off gut parasites

New research from the University of Pittsburgh reveals how the immune system defends against intestinal parasitic worms, or helminths, one of the most common infections worldwide in communities with limited access to clean ...

Oncology & Cancer

Cancer-fighting radioisotope being optimized for therapeutic use

A promising breakthrough in cancer treatment is taking shape at the University of Missouri Research Reactor (MURR), where scientists are developing a powerful radioisotope that could one day precisely target and destroy cancer ...

Immunology

Surprising finding could pave way for universal cancer vaccine

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system ...

Oncology & Cancer

Novel complex induces immunogenic cancer cell death

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the immune system that something ...

Diseases, Conditions, Syndromes

How lung repair mechanisms can help fight against tuberculosis

New research has found that delivering a stronger form of the tuberculosis vaccine directly to the lungs can help generate protective immune cells to help fight the disease. The research is published in the journal Mucosal ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Obstetrics & gynaecology

Boosting immune cell tolerance may help prevent early pregnancy loss

Recurrent pregnancy loss can be devastating and exert a major impact on women, their partners, and society more broadly, but currently there are few options for effective therapies. Over several years, there has been mounting ...

Diseases, Conditions, Syndromes

Studies pinpoint immune cells and proteins linked to long COVID

Researchers at the University of Alberta have pinpointed two proteins that could serve as markers for identifying patients with long COVID—a discovery that may lead to treatments that will bring better quality of life for ...

Diseases, Conditions, Syndromes

'Assassin' cells found to play a key role in deadly drug reactions

Researchers have identified the skin cells responsible for orchestrating cases of two of the most life-threatening drug reactions. Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) cause the skin and mucous ...

Immunology

Delayed antibody treatment may improve efficacy of mRNA vaccines

Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and ...

Oncology & Cancer

Lymph node-like structures may trigger the demise of cancer tumors

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers ...

Diseases, Conditions, Syndromes

How the novel antibody felzartamab impacts IgA nephropathy

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal ...